# BPC-157 10mg

> The Body Protective Compound.

Canonical PDP: https://aurex.bio/products/bpc-157-10mg
Research-data API: https://aurex.bio/api/research-data/bpc-157-10mg

## Catalog facts
- Name: BPC-157
- SKU: `BC10`
- Category: healing
- Dosage: 10mg
- Vials per kit: 1
- Total mass: 10mg
- Half-life: ~4 hours (SC)
- Reconstitution: 2ml bacteriostatic water → 5mg/ml

## Pricing
- One-time: $90 (MSRP $119.97 · list $104.97)
- Subscribe & save: $81
- Stack-tier floor (3+ vials in cart): $72
- Crypto checkout (BTC, ETH, USDC, USDT, LTC): -8% across cart
- Free tracked US shipping at $200+ subtotal, otherwise $18 flat

## Stock
- Current: 10 vials

## Pitch
Gastric-derived 15-amino-acid peptide. Researched for soft-tissue repair, angiogenesis, and inflammation modulation pathways.

## Mechanism
BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence in human gastric juice. In vitro it modulates the nitric oxide system, accelerates fibroblast and tendon-cell migration, and upregulates VEGF and growth-hormone receptor expression in injured tissues.

## Common in-vitro applications
### Tendon + ligament fibroblast migration
Wound-closure scratch assays in primary tendon fibroblast cultures.
Working range: `1 µg/mL to 10 µg/mL`

### Angiogenesis
VEGF/eNOS upregulation studies in HUVECs and rodent cardiac tissue homogenates.
Working range: `10 ng/mL to 1 µg/mL`

### NO-system modulation
L-NAME / L-arginine antagonism assays measuring nitric oxide pathway sensitivity.
Working range: `10 µg/kg models`

## Researchers commonly co-treat with
- **TB-500 (Thymosin Beta-4)** — Co-treatment in tendon-repair scratch assays — complementary actin-binding + angiogenesis pathways.
- **GHK-Cu** — Parallel evaluation in fibroblast migration and ECM remodeling models.

## Storage and handling
- Lyophilized: −20°C or below, desiccated
- Reconstituted: 2–8°C, use within 30 days
- Light + air: Protect from light and air
- Solubility: Soluble in bacteriostatic water (0.9% benzyl alcohol)

## Selected peer-reviewed citations
- Sikiric P, et al. (2018). Stable Gastric Pentadecapeptide BPC 157. *Current Pharmaceutical Design*.
- Chang CH, et al. (2014). Pentadecapeptide BPC 157 enhances the growth of tendon fibroblasts. *Journal of Applied Physiology*.
- Hsieh MJ, et al. (2017). BPC 157 modulates the eNOS/VEGF pathway. *Journal of Molecular Medicine*.

## Bundled in research stacks
- [The Recovery Stack](https://aurex.bio/stacks/healing-stack) — $289.97

## Released batches
- `AUR-26Q2-BPC-001` — 99.50% HPLC-UV · tested 2026-03-28 · Janoshik Analytical → https://aurex.bio/research/batch/AUR-26Q2-BPC-001

## Verification
- Independently re-tested at Janoshik Analytical (HPLC-UV at 214 nm + ESI mass spectrometry).
- 100% purity-replacement guarantee: any batch failing an independent retest gets reshipped free.
- Per-batch QR code on the outer kit card resolves to https://aurex.bio/research/batch/[id].

## Compliance
Aurex is a chemical supplier and is **not** a compounding pharmacy or an outsourcing facility as defined under the Federal Food, Drug, and Cosmetic Act. Aurex products are not pharmaceuticals, food additives, or dietary supplements. Aurex does not provide dosage or use guidance — Federal regulations governing research-chemical distribution prohibit it. Distributed strictly for in-vitro laboratory research by qualified researchers 21+. Not for human or veterinary use. Not FDA approved.

---
Wiki: https://aurex.bio/wiki · API: https://aurex.bio/api · Bot: https://t.me/Aurex33bot
Generated 2026-05-04